A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers ...

By contrast, one of the latest commercial blood tests — designed to measure minute levels of amyloid-β and tau that have exited the brain and begun circulating in the bloodstream — was more ...

The technology is being developed by a company called C2N Diagnostics, which also made earlier blood tests for Alzheimer’s.

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

Researchers have developed a blood test that can not only help diagnose Alzheimer’s disease, but also provide information to doctors on how far the disease has progressed.

A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...

Researchers developing benchmarks for a blood-based test like those for measuring blood glucose and cholesterol ...

P-tau 217 is a “beautiful marker for Alzheimer ... while those who implemented less than 60% were low compliance. Periodic blood tests tracked progress in various brain biomarkers.